1. Home
  2. NYXH vs FUND Comparison

NYXH vs FUND Comparison

Compare NYXH & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • FUND
  • Stock Information
  • Founded
  • NYXH 2009
  • FUND 1988
  • Country
  • NYXH Belgium
  • FUND Canada
  • Employees
  • NYXH N/A
  • FUND N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • FUND Investment Managers
  • Sector
  • NYXH Health Care
  • FUND Finance
  • Exchange
  • NYXH Nasdaq
  • FUND Nasdaq
  • Market Cap
  • NYXH 222.3M
  • FUND 214.8M
  • IPO Year
  • NYXH 2021
  • FUND N/A
  • Fundamental
  • Price
  • NYXH $5.78
  • FUND $7.29
  • Analyst Decision
  • NYXH Strong Buy
  • FUND
  • Analyst Count
  • NYXH 4
  • FUND 0
  • Target Price
  • NYXH $14.50
  • FUND N/A
  • AVG Volume (30 Days)
  • NYXH 117.0K
  • FUND 32.5K
  • Earning Date
  • NYXH 05-14-2025
  • FUND 01-01-0001
  • Dividend Yield
  • NYXH N/A
  • FUND 6.64%
  • EPS Growth
  • NYXH N/A
  • FUND N/A
  • EPS
  • NYXH N/A
  • FUND 0.93
  • Revenue
  • NYXH $4,680,609.00
  • FUND N/A
  • Revenue This Year
  • NYXH $323.07
  • FUND N/A
  • Revenue Next Year
  • NYXH $204.30
  • FUND N/A
  • P/E Ratio
  • NYXH N/A
  • FUND $8.33
  • Revenue Growth
  • NYXH 3.98
  • FUND N/A
  • 52 Week Low
  • NYXH $5.55
  • FUND $6.75
  • 52 Week High
  • NYXH $12.21
  • FUND $8.47
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 34.87
  • FUND 58.45
  • Support Level
  • NYXH $6.03
  • FUND $7.10
  • Resistance Level
  • NYXH $6.66
  • FUND $7.35
  • Average True Range (ATR)
  • NYXH 0.33
  • FUND 0.09
  • MACD
  • NYXH 0.11
  • FUND 0.03
  • Stochastic Oscillator
  • NYXH 15.38
  • FUND 79.69

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About FUND Sprott Focus Trust Inc.

Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.

Share on Social Networks: